
Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
EU Council president: Ukraine should receive binding guarantees - 2
Employers and staff feel effect of fuel price rise - 3
Winona Ryder didn't take the 'Stranger Things' plot lightly. How 'otherworldly' grief and a kidnapping in her hometown informed her character. - 4
From Educational Loans to Obligation Free: Independence from the rat race Accomplished - 5
Woman shocked to welcome baby after experiencing stomach pain on Christmas
6 Useful Home Espresso Machines
Doomed SpaceX Starlink satellite photographed from orbit
'Harmonious' meeting between Merz, Lula despite Belém controversy
German mid-sized firms gloomy on outlook, survey finds
Reactions as Artemis II astronauts lift off on historic lunar mission
Vaccine committee votes to scrap universal hepatitis B shots for newborns despite outcry from children’s health experts
At 72, Kathie Lee Gifford says aging isn’t what she expected. 'The golden years? It’s a lie.’
Step by step instructions to Safeguard Your Teeth During Sports Exercises
Insight: Pills, TikTok, weight-loss apps and the consumer-driven future of GLP-1s













